Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 10)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
In-Utero Sugar Restriction Cuts Offspring's Risk for Diabetes, Hypertension
THURSDAY, Nov. 7, 2024 – Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes and hypertension, according to a study published...
U.S. Diabetes Rates Rise to Nearly 1 in 6 Adults
WEDNESDAY, Nov. 6, 2024 – Nearly 16% of American adults – that's close to 1 in 6 – now has diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention....
Diabetes Can Damage Your Eyes' Retinas: An Expert Explains
TUESDAY, Nov. 5, 2024 – People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal damage is one of them. “Diabetes can silently d...
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
TUESDAY, Nov. 5, 2024 – Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover t...
More Hot Flashes Could Mean Higher Odds for Type 2 Diabetes
MONDAY, Nov. 4, 2024 – Menopausal women with frequent hot flashes and night sweats are more likely to develop type 2 diabetes, a new study warns. Middle-aged women who regularly suffer those...
World War II Data Shows Impact of Sugar on Kids' Health
MONDAY, Nov. 4, 2024 – The home front hardships of World War II illustrate how too much sugar is harming people’s health today, a new study shows. British children who endured wartime rationing of s...
Weight-Loss Surgery for Teens Brings Lasting Benefit
FRIDAY, Nov. 1, 2024 – Hillary Fisher thinks receiving weight-loss surgery as a teenager put her on the path to a better life. Fisher is one of 260 teens who participated in a long-term study which...
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
FRIDAY, Nov. 1, 2024 – Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of...
Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM
FRIDAY, Nov. 1, 2024 – For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic...
Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
FRIDAY, Nov. 1, 2024 – Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D), according to a research letter published online...
ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in Women
FRIDAY, Nov. 1, 2024 – Chronic kidney disease (CKD) cases and deaths in women surged worldwide between 1990 and 2021, according to a study presented at Kidney Week, the annual meeting of the...
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
THURSDAY, Oct. 31, 2024 – A new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds...
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
WEDNESDAY, Oct. 30, 2024 – There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29...
AI Can Help ID Patients With Diabetes at Highest Risk for Cardiomyopathy
WEDNESDAY, Oct. 30, 2024 – Machine learning can help identify individuals with diabetes at high risk for diabetic cardiomyopathy (DbCM), according to a study published online Sept. 6 in the European...
Eucaloric Carbohydrate-Restricted Diet Improves β-Cell Function in T2DM
FRIDAY, Oct. 25, 2024 – A eucaloric carbohydrate-restricted (CR) diet improves β-cell response to glucose in patients with type 2 diabetes (T2D), according to a study published online Oct. 22 in the ...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Farxiga, Jardiance, Lantus Solostar, Humalog, Novolog, liraglutide, Janumet, insulin glargine, tirzepatide, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, dulaglutide, Glucophage, Invokana, insulin degludec, Humulin N